nach oben

Erschienen in:

29.09.2018 | Insomnie | Zertifizierte Fortbildung

Schlaf-Wach-Störungen

Insomnie bei neurologischen Erkrankungen

verfasst von: Prof. Dr. med. Geert Mayer

Erschienen in: DNP – Die Neurologie & Psychiatrie | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schlaf-Wach-Störungen können Vorboten von neurologischen Erkrankungen oder komorbide Störungen sein. Bei neurologischen Erkrankungen ist die Prävalenz sehr hoch. Lesen Sie hier, worauf es bei Insomnien im Zusammenhang mit Demenz, Epilepsie, Multipler Sklerose, Morbus Parkinson und Schlaganfall ankommt.

Bassetti CL, Ferini-Strambi L, Brown S, Adamantidis A, Benedetti F et al. Neurology and psychiatry: waking up to opportunities of sleep: State of the art and clinical/research priorities for the next decade. Eur J Neurol 2015; 22(10):1337–54CrossRef

Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation 2011; 124:2073–81CrossRef

Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep 2010; 33:739–44CrossRef

Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007; 30:274–80PubMed

DGN Leitlinie Insomnie; AWMF Registriernr. 030-045

Riemann D, Baglioni C, Bassetti C et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26:675–700CrossRef

WHO. Kapitel V—F51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf, 1992

American Academy of Sleep Medicine (Hrsg) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien. 2014

Riemann D et al. Leitlinie S3 „Nicht erholsamer Schlaf/Schlafstörungen Kapitel Insomnie bei Erwachsenen“. Somnologie 2017; 21:2–44CrossRef

10.

Morin CM, Drake CL, Harvey AG et al. Insomnia disorder. Nature Reviews 2015; 1:1–18

11.

Koenigs M, Holliday J, Solono J et al. Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 2010; 30:16041–3CrossRef

12.

Spiegelhalder K, Regen W, Feige B et al. Increased EEG sigma and beta power during NREM sleep in primary insomnia. Biol Psychol 2012; 91:329–33CrossRef

13.

Baglioni C, Regen W, Teghen A et al. Sleep changes in the disorderof insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 2014; 18:195–213CrossRef

14.

Alibhai FJ, LaMarre J, Reitz CJ, Tsimakouridze EV, Kroetsch JT, Bolz SS, Shulman A, Steinberg S, Burris TP, Oudit GY, Martino TA. Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. J Mol Cell Cardiol 2017; 105:24–37CrossRef

15.

Potvin O, Lorrain D, Forget H, Dubé M, Grenier S, Préville M et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35:491–9CrossRef

16.

Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer’s disease: dementia. Int Psychogeriatr 2016; 28:1409–24CrossRef

17.

Branger P, Arenaza-Urquijo EM, Tomadesso C, Mézenge F, André C, de Flores R et al. Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging 2016; 41:107–14CrossRef

18.

Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E et al. Prevalence of Sleep Disturbances in Mild Cognitive Impairment and Dementing Disorders: A Multicenter Italian Clinical Cross-Sectional Study on 431 Patients. Dement Geriatr Cogn Disord 2012; 33:50–8CrossRef

19.

McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2016; 11:CD009178PubMed

20.

Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M et al. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med 2016; 165(2):103–12CrossRef

21.

van Maanen A, Meijer AM, van der Heijden KB, Oort FJ. The effects of light therapy on sleep problems: A systematic review and meta-analysis. Sleep Med Rev 2016; 29:52–62CrossRef

22.

Vendrame M, Yang B, Jackson S, Auerbach SH. Insomnia and epilepsy: a questionnaire-based study. J Clin Sleep Med 2013; 9(2):141–6PubMedPubMedCentral

23.

Macedo PJOM, Oliveira PS, Foldvary-Schaefer N, Gomes MDM. Insomnia in people with epilepsy: A review of insomnia prevalence, risk factors and associations with epilepsy-related factors. Epilepsy Res 2017; 135:158–67CrossRef

24.

Yazdi Z, Sadeghniiat-Haghighi K, Naimian S, Zohal MA, Ghaniri M. Prevalence of Sleep Disorders and their Effects on Sleep Quality in Epileptic Patients. Basic and Clinical Neuroscience 2013; 4:36–41PubMedPubMedCentral

25.

Yang KI, Grigg-Damberger M, Andrews N, O’Rourke C, Bena J et al. Severity of self-reported insomnia in adults with epilepsy is related to comorbid medical disorders and depressive symptoms. Epilepsy & Behavior 2016; 60:27–32CrossRef

26.

Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 2014; 10(9):1025–31PubMedPubMedCentral

27.

Veauthier C, Gaede G, Radbruch H, Sieb J-P, Wernecke K-D, Paul F. Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity. Neuropsychiatr Dis Treat 2015; 11:2323CrossRef

28.

Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS). J Neurol 2007; 254(S2):58–64

29.

Veauthier et al. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis related fatigue. The EPMA Journal 2016; 7:25CrossRef

30.

Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2011; 34(2):92–101CrossRef

31.

Asano M, Finlayson ML. Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication. Mult Scler Int 2014; 2014:1–12CrossRef

32.

Ylikoski A, Martikainen K, Partinen M. Parkinson’s disease and chronic insomnia disorder. sleepmedicine 2015; 16(suppl 1):S248

33.

Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A et al. Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations. Mov Disord 2010;;25(16):2704–16CrossRef

34.

Ylikoski A, Martikainen K, Sieminski M, Partinen M. Parkinson’s disease and insomnia. Neurol Sci 2015; 36(11):2003–10CrossRef

35.

Hsiao YH, Chen YT, Tseng CM, Wu LA, Perng DW et al. Sleep disorders and an increased risk of Parkinson’s disease in individuals with non-apnea sleep disorders: a population-based cohort study. J Sleep Res 2017; 26(5):623–8CrossRef

36.

Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD. Changes in insomnia subtypes in early Parkinson disease. Neurology 2017; 88(4):352–8CrossRef

37.

Hu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinson’s disease. Parkinsonism Relat Disord 2016; 33:51–7CrossRef

38.

Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D et al. Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers. PLoS One 2015; 10(7): e0132368CrossRef

39.

Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, Comella CL, Cantor C, Hyer L. Treatment of Insomnia in Parkinson’s Disease: A controlled trial of eszopiclone and placebo. Mov Disord 2010; 25(11):1708–14CrossRef

40.

Rodrigues TM, Castro Caldas A, Ferreira JJ. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson’s disease: Systematic review and meta-analysis. Parkinsonism Relat Disord 2016; 27:25–34CrossRef

41.

Leeman AL, O’Neill CJ, Nicholson PW et al. Parkinson’s disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987; 24(5):637–43CrossRef

42.

Iranzo A, Valldeoriola F, Santamaría J, Tolosa E, Rumià J. Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72(5):661–4CrossRef

43.

Humbert M, Findley J, Hernandez-Con M, Chahine LM. Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series. NPJ Parkinsons Dis 2017; 3:25CrossRef

44.

Patel S, Ojo O, Genc G, Oravivattanakul S, Huo Y et al. A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease. J Clin Movement Disorders 2017; 4:16CrossRef

45.

Fernández-Pajarín G, Sesar Á, Ares B, Castro A. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study. J Parkinsons Dis 2016; 6(4):787–92CrossRef

46.

Leppävuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjuntti T. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002; 14:90–7CrossRef

47.

Baglioni C, Nissen C, Schweinoch A, Riemann D, Spiegelhalder K, Berger M et al. Polysomnographic Characteristics of Sleep in Stroke: A Systematic Review and Meta-Analysis. PLoS ONE 2016; 11(3):e0148496CrossRef

48.

Helbig AK, Stöckl D, Heier M, Ladwig KH, Meisinger C. Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study. PLoS ONE 2015; 10(7):e0134480CrossRef

49.

Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt T, Trolle Lagerros Y. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol 2013; 28(6):463–73CrossRef

50.

Zhang W, Li F, Zhang T. Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trial. Neural Regen Res 2017; 12(8):1299–307CrossRef

51.

Glozier N, Moullaalib TJ, Sivertsen B, Kim D, Mead G et al. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study. Cerebrovasc Dis Extra 2017; 7:9–20CrossRef

52.

Tang WK, Grace Lau C, Mok V, Ungvari GS, Wong KS. Insomnia and health-related quality of life in stroke. Top Stroke Rehabil 2015; 22(3):201–7CrossRef

53.

Siengsukon CF, Boyd LA. Sleep to learn after stroke: implicit and explicit off-line motor learning. Neurosci Lett 2009; 451(1):1–5CrossRef

Titel: Schlaf-Wach-Störungen
Insomnie bei neurologischen Erkrankungen
verfasst von: Prof. Dr. med. Geert Mayer
Publikationsdatum: 29.09.2018
Verlag: Springer Medizin
Schlagwörter: Insomnie
Demenz
Demenz
Restless-Legs-Syndrom
Parkinson-Krankheit
Apoplex
Epilepsie
Multiple Sklerose
Erschienen in: DNP – Die Neurologie & Psychiatrie / Ausgabe 5/2018
Print ISSN: 2731-8168
Elektronische ISSN: 2731-8176
DOI: https://doi.org/10.1007/s15202-018-1884-y

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Adhärenz bei MS: Therapiezufriedenheit ist das A und O

Wirksamkeit und Sicherheit der MS-Behandlung mit Ocrelizumab

Telefonberatung „Plan Baby bei MS“ gefördert

Läsionen des N. peronaeus

Genetische generalisierte Epilepsien — erste Erfahrungen mit Brivaracetam

Aufbauhilfe für Nervenzellen